YDES

NASD YD Bio Limited
Oct 11, 2026 · 8:34 AM ET EOD Market Closed

$6.73 ↑ +0.00 (+0.00%) Trading Up from the previous close of $6.73, $0.36 below the day’s high of $7.09

YTD change
-44.79%
vs 20-day SMA
+29.32%
vs 200-day SMA
+11.85%

Price ranges

Previous day
$5.61 $7.09
open $5.71 close $6.73
+$1.02 (+17.86%)
Today
$5.61 $7.09
$6.73
Past week
$5.20 $8.43
from $7.81 now $6.73
-$1.08 (-13.83%)
Past month
$2.42 $8.43
from $3.90 now $6.73
+$2.83 (+72.56%)
This year
$1.70 $13.11
from $12.19 now $6.73
-$5.46 (-44.79%)

Price & Performance

+0.99 (+17.25%) / 6M

$1.40$3.80$6.21$8.61Apr 13Jul 13Oct 9

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral
  • The stock is 73.1% away from all-time highs of $25.00
  • YDES is down 45% since the beginning of the year
  • YDES is down 64% over the past 12 months
  • YDES is up 73% over the past 1 month
  • 1% of all YDES investors are betting against YDES

YDES reads neutral: price sits above both the 20- and 200-day averages, the 12-month move is -63.5%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable N/A
EPS N/A
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio N/A
Enterprise value $407.4M
Beta -0.52

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$2.7M
Debt$5.0
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Health Care and Social Assistance
Sub Sector Ambulatory Health Care Services
Market cap $476.4M

YD Bio Ltd. is a biotechnology company building an integrated healthcare platform across regulated diagnostics, clinical services, and commercial healthcare markets. It operates DNA methylation–based oncology testing programs under an LDT-first strategy and provides compliant life science distribution and clinical trial supply chain services to pharmaceutical and biotechnology partners. The company’s offerings include cancer detection products, regenerative ophthalmology solutions, and exosome-based technologies. YD Bio was founded on February 6, 2024 and is headquartered in Taipei, Taiwan.

Competitor comparison

TickerCompany PriceChange
DGX Quest Diagnostics Incorporated $230.97 +0.07%
LH Labcorp Holdings Inc. $312.15 -0.65%
SKHHY Sonic Healthcare Limited Sponsored ADR $13.01 +0.39%
GRAL GRAIL Inc $140.58 +6.01%
BLLN BillionToOne, Inc. Class A $98.09 +2.81%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.